Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 59,60
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 76,47
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 84 pages. 9.25x6.25x0.50 inches. In Stock.
Sprache: Englisch
Verlag: Springer, Berlin, Springer International Publishing, Springer, 2016
ISBN 10: 3319469053 ISBN 13: 9783319469058
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book discusses the immunotherapeutic potential of Interleukin 12 in the context of clinical oncology, as well as antitumor effects confirmed in preclinical studies and clinical trials in cancer immunotherapy. Due to its ability to activate both innate (NK cells) and adaptive (cytotoxic T lymphocytes) immunities, Interleukin 12 (IL-12) has been regarded as a promising candidate for tumor immunotherapy. However, despite the encouraging results in animal models, only very modest antitumor effects have been confirmed in early clinical trials. Recently, several clinical studies have been initiated in which IL-12 was applied as an adjuvant in cancer vaccines, in gene therapy including locoregional injections of IL-12 plasmid, and in the form of tumor-targeting immunocytokines (IL-12 fused to monoclonal antibodies).
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology | Witold Lasek (u. a.) | Taschenbuch | vii | Englisch | 2016 | Springer | EAN 9783319469058 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.